The global cold laser therapy market revenue was US$ 112.4 million in 2022. The global market is forecast to reach US$ 165.6 million by 2031, growing at a CAGR of 4.4% during the forecast period from 2023 to 2031.
Low-intensity lasers or light-emitting diodes (LEDs) are used in cold laser therapy, sometimes term as low-level laser therapy (LLLT), to promote healing and lessen pain and inflammation. The body's cells are stimulated to produce more energy and aid in healing when the laser's photons penetrate the skin and enter the body. Numerous ailments, including musculoskeletal injuries, joint discomfort, neuropathy, and skin disorders are treated with cold laser treatment.
Market Drivers
Regional Outlook
North America is the dominant region in the laser therapy market, accounting for the largest market share in terms of revenue. This is a result of a number of things, such as the existence of a strong healthcare infrastructure, the high prevalence of chronic illnesses, and the expanding use of cutting-edge laser therapy technology. The increasing incidence of chronic diseases, including cancer, arthritis, and chronic pain in North America is the major factor influencing the market growth. The demand for laser therapy equipment and services in the area is owing to the growing usage of laser therapy as a treatment option for various ailments. Additionally, the North American region's developed healthcare infrastructure has made it simpler for healthcare professionals to embrace and treat patients with cutting-edge laser therapy technologies.
Segmentation Outlook
Based on the product, in 2022, the continuous laser devices segment dominated the global market. Constant laser radiation stimulates the lymphatic system and blood flow to help relieve edema and inflammation. The pulsed laser energy also has analgesic effects in the treatment area by obstructing the transmission of pain signals to the brain. Additionally, continuous laser devices can be scanned to deliver tissue exposure time that generates a tissue effect comparable to that of pulsed lasers, increasing the efficacy of therapy.
In terms of the application, in 2022, the dermatological segment accounted for the highest revenue share. This is due to the widespread use of laser technology in dermatology for both cosmetic and therapeutic purposes. The rising demand for non-invasive and minimally invasive cosmetic procedures is one of the main factors boosting the dermatology market.
Prominent Companies
Segmentation Outline
The global cold laser therapy market segmentation focuses on Product, Technology, Application, End User, and Region.
By Product
By Technology
By Application
By End-User
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL COLD LASER THERAPY MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL COLD LASER THERAPY MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL COLD LASER THERAPY MARKET, BY PRODUCT
5.1 OVERVIEW
5.2 CONTINUOUS LASER DEVICES
5.3 PULSE LASER DEVICES
5.4 COMBINATION LASER DEVICES
6 GLOBAL COLD LASER THERAPY MARKET, BY TECHNOLOGY
6.1 OVERVIEW
6.2 SINGLE WAVELENGTH COLD LASER THERAPY DEVICES
6.3 MULTIPLE WAVELENGTH COLD LASER THERAPY DEVICES
7 GLOBAL COLD LASER THERAPY MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 PAIN MANAGEMENT
7.3 ARTHRITIS
7.4 WOUND HEALING
7.5 NERVE REGENERATION
7.6 DERMATOLOGY
7.7 MUSCULOSKELETAL
7.8 OTHERS
8 GLOBAL COLD LASER THERAPY MARKET, BY END-USER
8.1 OVERVIEW
8.2 HOSPITALS
8.3 SPECIALTY CLINICS
8.4 AMBULATORY SURGICAL CENTERS
8.5 HOMECARE SETTINGS
9 GLOBAL COLD LASER THERAPY MARKET, BY GEOGRAPHY
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA MARKET SNAPSHOT
9.2.2 U.S.
9.2.3 CANADA
9.2.4 MEXICO
9.3 EUROPE
9.3.1 EUROPE MARKET SNAPSHOT
9.3.2 WESTERN EUROPE
9.3.2.1 THE UK
9.3.2.2 GERMANY
9.3.2.3 FRANCE
9.3.2.4 ITALY
9.3.2.5 SPAIN
9.3.2.6 REST OF WESTERN EUROPE
9.3.3 EASTERN EUROPE
9.3.3.1 POLAND
9.3.3.2 RUSSIA
9.3.3.3 REST OF EASTERN EUROPE
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC MARKET SNAPSHOT
9.4.2 CHINA
9.4.3 JAPAN
9.4.4 INDIA
9.4.5 AUSTRALIA & NEW ZEALAND
9.4.6 ASEAN
9.4.7 REST OF ASIA PACIFIC
9.5 MIDDLE EAST & AFRICA
9.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
9.5.2 UAE
9.5.3 SAUDI ARABIA
9.5.4 SOUTH AFRICA
9.5.5 REST OF MEA
9.6 SOUTH AMERICA
9.6.1 SOUTH AMERICA MARKET SNAPSHOT
9.6.2 BRAZIL
9.6.3 ARGENTINA
9.6.4 REST OF SOUTH AMERICA
10 GLOBAL COLD LASER THERAPY MARKET COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPANY MARKET RANKING
10.3 KEY DEVELOPMENT STRATEGIES
11 COMPANY PROFILES
11.1 APIRA SCIENCE INC.
11.1.1 OVERVIEW
11.1.2 FINANCIAL PERFORMANCE
11.1.3 PRODUCT OUTLOOK
11.1.4 KEY DEVELOPMENTS
11.2 B-CURE LASER AUSTRALIA
11.2.1 OVERVIEW
11.2.2 FINANCIAL PERFORMANCE
11.2.3 PRODUCT OUTLOOK
11.2.4 KEY DEVELOPMENTS
11.3 ERCHONIA CORPORATION
11.3.1 OVERVIEW
11.3.2 FINANCIAL PERFORMANCE
11.3.3 PRODUCT OUTLOOK
11.3.4 KEY DEVELOPMENTS
11.4 THERALASE INC.
11.4.1 OVERVIEW
11.4.2 FINANCIAL PERFORMANCE
11.4.3 PRODUCT OUTLOOK
11.4.4 KEY DEVELOPMENTS
11.5 DJO GLOBAL, INC. (COLFAX CORPORATION)
11.5.1 OVERVIEW
11.5.2 FINANCIAL PERFORMANCE
11.5.3 PRODUCT OUTLOOK
11.5.4 KEY DEVELOPMENTS
11.6 BTL CORPORATE
11.6.1 OVERVIEW
11.6.2 FINANCIAL PERFORMANCE
11.6.3 PRODUCT OUTLOOK
11.6.4 KEY DEVELOPMENTS
11.7 BIOLIGHT TECHNOLOGIES LLC
11.7.1 OVERVIEW
11.7.2 FINANCIAL PERFORMANCE
11.7.3 PRODUCT OUTLOOK
11.7.4 KEY DEVELOPMENTS
11.8. THOR PHOTOMEDICINE LTD
11.8.1 OVERVIEW
11.8.2 FINANCIAL PERFORMANCE
11.8.3 PRODUCT OUTLOOK
11.8.4 KEY DEVELOPMENTS
11.9 IRRADIA
11.9.1 OVERVIEW
11.9.2 FINANCIAL PERFORMANCE
11.9.3 PRODUCT OUTLOOK
11.9.4 KEY DEVELOPMENTS
11.10 PHOTOMEDEX
11.10.1 OVERVIEW
11.10.2 FINANCIAL PERFORMANCE
11.10.3 PRODUCT OUTLOOK
11.10.4 KEY DEVELOPMENTS
11.11 LEXINGTON INTERNATIONAL, LLC
11.11.1 OVERVIEW
11.11.2 FINANCIAL PERFORMANCE
11.11.3 PRODUCT OUTLOOK
11.11.4 KEY DEVELOPMENTS
11.12 MICROLIGHT CORPORATION
11.12.1 OVERVIEW
11.12.2 FINANCIAL PERFORMANCE
11.12.3 PRODUCT OUTLOOK
11.12.4 KEY DEVELOPMENTS
11.13 APOLLO (PIVOTAL HEALTH CARE LLC)
11.13.1 OVERVIEW
11.13.2 FINANCIAL PERFORMANCE
11.13.3 PRODUCT OUTLOOK
11.13.4 KEY DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved